These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Deciphering lung granulomas in HIV & TB co-infection: unveiling macrophages aggregation with IL6R/STAT3 activation. Li Q; Wang C; Gou J; Kitanovski S; Tang X; Cai Y; Zhang C; Zhang X; Zhang Z; Qiu Y; Zhao F; Lu M; He Y; Wang J; Lu H Emerg Microbes Infect; 2024 Dec; 13(1):2366359. PubMed ID: 38855910 [TBL] [Abstract][Full Text] [Related]
8. Coinfection of COVID-19 and Tuberculosis in Uganda. Nuwagira E; Mpagama SG; Katusiime A; Natamba B; Baluku JB; Lai PS Am J Trop Med Hyg; 2023 Jun; 108(6):1240-1243. PubMed ID: 37094784 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoir. Xun J; Qi T; Zou L; Tang Q; Shen Y; Yang J; Xie L; Ji Y; Zhang R; Liu L; Wang J; Steinhart C; Wang Z; Tang Y; Song W; Sun J; Cheng J; Le X; Wu H; He X; Chen R; Chen J; Lu H AIDS Res Ther; 2020 Oct; 17(1):63. PubMed ID: 33076959 [TBL] [Abstract][Full Text] [Related]
10. Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. Srikantiah P; Wong JK; Liegler T; Walusimbi M; Mayanja-Kizza H; Kayanja HK; Mugerwa RD; Charlebois ED; Boom WH; Whalen CC; Havlir DV J Acquir Immune Defic Syndr; 2008 Dec; 49(4):458-60. PubMed ID: 19011423 [No Abstract] [Full Text] [Related]
11. Higher plasma interleukin - 6 levels are associated with lung cavitation in drug-resistant tuberculosis. Maseko TG; Ngubane S; Letsoalo M; Rambaran S; Archary D; Samsunder N; Perumal R; Chinappa S; Padayatchi N; Naidoo K; Sivro A BMC Immunol; 2023 Aug; 24(1):26. PubMed ID: 37653422 [TBL] [Abstract][Full Text] [Related]
12. Prevalence, Epidemiological, and Clinical Profile of Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis in the Coronavirus Disease 2019 Context in Health Facilities in the East Region, Cameroon. François Anicet OA; Kouanfack C; Dama U; Nkfusai CN; Abanda JN; Tchoffo D; Mbu PN; Yoniene PY Int J MCH AIDS; 2024; 13():e006. PubMed ID: 38742165 [TBL] [Abstract][Full Text] [Related]
13. Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative study. Machona MS; Muloiwa R; Porter M; Peter J; Lehloenya RJ J Allergy Clin Immunol Glob; 2024 Aug; 3(3):100276. PubMed ID: 38946893 [TBL] [Abstract][Full Text] [Related]
14. Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand. Kroon E; Pham PT; Sirivichayakul S; Trichavaroj R; Colby DJ; Pinyakorn S; Phanuphak N; Sanders-Buell E; van Griensven F; Kijak GH; Kim JH; Michael NL; Robb ML; Ananworanich J; De Souza MS; Tovanabutra S; AIDS; 2018 Oct; 32(16):2373-2381. PubMed ID: 30096068 [TBL] [Abstract][Full Text] [Related]
15. Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda. Stein CM; Nsereko M; Malone LL; Okware B; Kisingo H; Nalukwago S; Chervenak K; Mayanja-Kizza H; Hawn TR; Boom WH Clin Infect Dis; 2019 May; 68(10):1705-1712. PubMed ID: 30165605 [TBL] [Abstract][Full Text] [Related]
16. Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults. Menzies D; Adjobimey M; Ruslami R; Trajman A; Sow O; Kim H; Obeng Baah J; Marks GB; Long R; Hoeppner V; Elwood K; Al-Jahdali H; Gninafon M; Apriani L; Koesoemadinata RC; Kritski A; Rolla V; Bah B; Camara A; Boakye I; Cook VJ; Goldberg H; Valiquette C; Hornby K; Dion MJ; Li PZ; Hill PC; Schwartzman K; Benedetti A N Engl J Med; 2018 Aug; 379(5):440-453. PubMed ID: 30067931 [TBL] [Abstract][Full Text] [Related]
17. Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa. Chihota VN; Niehaus A; Streicher EM; Wang X; Sampson SL; Mason P; Källenius G; Mfinanga SG; Pillay M; Klopper M; Kasongo W; Behr MA; Gey van Pittius NC; van Helden PD; Couvin D; Rastogi N; Warren RM PLoS One; 2018; 13(8):e0200632. PubMed ID: 30067763 [TBL] [Abstract][Full Text] [Related]
18. Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. Zhao Y; Fox T; Manning K; Stewart A; Tiffin N; Khomo N; Leslie J; Boulle A; Mudaly V; Kock Y; Meintjes G; Wasserman S Clin Infect Dis; 2019 Apr; 68(9):1522-1529. PubMed ID: 30165431 [TBL] [Abstract][Full Text] [Related]
19. Corticosteroids as an adjunct to tuberculosis therapy. Schutz C; Davis AG; Sossen B; Lai RP; Ntsekhe M; Harley YX; Wilkinson RJ Expert Rev Respir Med; 2018 Oct; 12(10):881-891. PubMed ID: 30138039 [TBL] [Abstract][Full Text] [Related]